Meanwhile, TNFRSF25 is positively correlated with GSDMB expression in KIRC (rho = 0.795, p < 0.0001), PRAD (rho = 0.657, p < 0.0001), SKCM (rho = 0.587, p < 0.0001), head and neck squamous cell carcinoma (HNSC) (rho = 0.416, p < 0.0001), BLCA (rho = 0.36, p < 0.0001), and LUAD (rho = 0.332, p < 0.0001) as well (Figures 4C, E). Here, TNFRSF25 is linked to head and neck squamous cell carcinoma.